DMK
David M. Knott Portfolio holdings
AUM
$264M
This Quarter Return
+37.16%
1 Year Return
+57.14%
3 Year Return
+78.48%
5 Year Return
+218.77%
10 Year Return
–
AUM
$183M
AUM Growth
+$183M
(+16%)
Cap. Flow
-$38.2M
Cap. Flow
% of AUM
-20.83%
Top 10 Holdings %
Top 10 Hldgs %
60.99%
Holding
128
New
6
Increased
17
Reduced
13
Closed
35
Top Buys
| 1 |
FTAI Aviation
FTAI
|
$9.09M |
| 2 |
Kennedy-Wilson Holdings
KW
|
$3.2M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
$1.75M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$1.61M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$1.43M |
Top Sells
| 1 |
FS KKR Capital
FSK
|
$16.6M |
| 2 |
Ligand Pharmaceuticals
LGND
|
$8.95M |
| 3 |
BRSL
Brightstar Lottery PLC
BRSL
|
$4.45M |
| 4 |
Apollo Global Management
APO
|
$3.62M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$3.25M |
Sector Composition
| 1 | Healthcare | 41.22% |
| 2 | Financials | 16.44% |
| 3 | Industrials | 13.2% |
| 4 | Technology | 8.55% |
| 5 | Communication Services | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ligand Pharmaceuticals
LGND
$3.15B
| $30.5M | 16.67% | 273,041 -80,000 | -23% | -$8.95M |
|
|
SRCL
2
DELISTED
Stericycle Inc
SRCL
| $15.1M | 8.22% | 269,083 | – | – |
|
|
3
Apollo Global Management
APO
$77.9B
| $15M | 8.18% | 300,000 -72,500 | -19% | -$3.62M |
|
4
Upland Software
UPLD
$81.4M
| $14.1M | 7.71% | 406,500 -6,500 | -2% | -$226K |
|
|
5
FTAI Aviation
FTAI
$15.8B
| $9.09M | 4.96% | +700,000 | New | +$9.09M |
|
|
6
Alphabet (Google) Class C
GOOG
$2.58T
| $7.92M | 4.32% | 5,600 -2,300 | -29% | -$3.25M |
|
7
KKR & Co
KKR
$124B
| $5.56M | 3.03% | 180,000 -25,000 | -12% | -$772K |
|
|
8
FS KKR Capital
FSK
$5.11B
| $5.53M | 3.02% | 395,175 -1,185,525 | -75% | -$16.6M |
|
9
Calumet Specialty Products
CLMT
$1.41B
| $4.61M | 2.51% | 2,020,000 | – | – |
|
|
CCXI
10
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.32M | 2.36% | 75,033 -25,398 | -25% | -$1.46M |
|
11
Pfizer
PFE
$141B
| $4.31M | 2.35% | 131,900 | – | – |
|
12
LKQ Corp
LKQ
$8.39B
| $3.93M | 2.15% | 150,000 | – | – |
|
13
AbbVie
ABBV
$372B
| $3.71M | 2.02% | 37,769 +2,536 | +7% | +$249K |
|
|
14
Kennedy-Wilson Holdings
KW
$1.21B
| $3.2M | 1.74% | +210,000 | New | +$3.2M |
|
|
ZGNX
15
DELISTED
Zogenix, Inc.
ZGNX
| $2.85M | 1.56% | 105,607 +52,842 | +100% | +$1.43M |
|
16
Bristol-Myers Squibb
BMY
$96B
| $2.73M | 1.49% | 46,409 +500 | +1% | +$29.4K |
|
|
EIGR
17
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.53M | 1.38% | 263,748 | – | – |
|
|
BLU
18
DELISTED
BELLUS Health Inc.
BLU
| $2.47M | 1.35% | 238,611 -4,000 | -2% | -$41.4K |
|
|
KDMN
19
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.24M | 1.22% | 437,600 +55,700 | +15% | +$285K |
|
|
BDSI
20
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.2M | 1.2% | 505,530 | – | – |
|
21
JPMorgan Chase
JPM
$829B
| $2.17M | 1.18% | 23,050 | – | – |
|
|
TRIL
22
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.14M | 1.17% | 264,225 +127,725 | +94% | +$1.03M |
|
23
Xenon Pharmaceuticals
XENE
$2.98B
| $2.12M | 1.16% | 169,000 -6,204 | -4% | -$77.8K |
|
|
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.03M | 1.11% | 36,531 -23,000 | -39% | -$1.28M |
|
|
25
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.89M | 1.03% | 397,361 +337,371 | +562% | +$1.61M |
|